Answer
No, clinical data are insufficient to exclude a teratogenic effect following exposure to follitropin alfa (GONAL-f) during pregnancy, and there is no indication for its use during pregnancy.
Sources for this answer
- GONAL-f 75 IU (5.5 micrograms)Merck · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 19Document updated
Sources checked